NNG NanoGroup S.A.
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A. was incorporated in 2016 and is based in Warsaw, Poland.…
Industry Peers
BiotechnologyKey Statistics
About NanoGroup (WSE: NNG)
›
NanoGroup (WSE: NNG) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 2.040 PLN on 19 November 2026, down 19.7% over 52 weeks. Its 52-week range is 1.978 PLN to 3.200 PLN: the price is 36.3% below the high and 3.1% above the low.
Its market capitalisation is 86.96M PLN.
NanoGroup reports return on equity of -108.7% and revenue up 300.1% year over year.
It holds more cash than debt, a net cash position of 10.27M PLN. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.